A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways

Published:2020-02 Issue:2 Volume:27 Page:223-231.e4
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Benhamou Raphael I.,Angelbello Alicia J.,Wang Eric T.,Disney Matthew D.

Funder

Muscular Dystrophy Association

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model;Angelbello;Proc. Natl. Acad. Sci. U S A,2019

2. RNA structures as mediators of neurological diseases and as drug targets;Bernat;Neuron,2015

3. Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1;Chen;Anal. Bioanal. Chem.,2012

4. A small molecule microarray platform to select RNA internal loop-ligand interactions;Childs-Disney;ACS Chem. Biol.,2007

5. Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity;Childs-Disney;ACS Chem. Biol.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster;International Journal of Molecular Sciences;2023-09-16

2. Small Molecules Targeting Repeat Sequences Causing Neurological Disorders;Handbook of Chemical Biology of Nucleic Acids;2023

3. Extending the Degradation Toolkit –mRNATargeting as an Alternative Means to Affect Protein Levels;Inducing Targeted Protein Degradation;2022-11-25

4. A blood–brain penetrant RNA-targeted small molecule triggers elimination of r(G ₄ C ₂ ) ^exp in c9ALS/FTD via the nuclear RNA exosome;Proceedings of the National Academy of Sciences;2022-11-21

5. Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2;International Journal of Molecular Sciences;2022-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3